ICU Medical Inc. (ICUI)
139.52
-1.02 (-0.73%)
At close: Apr 15, 2025, 3:59 PM
138.42
-0.79%
After-hours: Apr 15, 2025, 05:46 PM EDT
ICU Medical Revenue Breakdown
| Period Ending | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
|---|---|---|---|---|---|---|
| Equipment revenue Revenue | 38.83M | 9.34M | n/a | 25.62M | 15.61M | 17.46M |
| Equipment revenue Revenue Growth | +315.69% | n/a | -100.00% | +64.18% | -10.64% | n/a |
| Other deferred revenue Revenue | 503K | n/a | n/a | 944K | 1.45M | 1.42M |
| Other deferred revenue Revenue Growth | n/a | n/a | -100.00% | -34.94% | +2.04% | n/a |
| Software revenue Revenue | 24.56M | 155K | n/a | 1.67M | 2.59M | 3.71M |
| Software revenue Revenue Growth | +15744.52% | n/a | -100.00% | -35.39% | -30.18% | n/a |
| Government Grant Revenue Revenue | 7.86M | 5.57M | n/a | 12.8M | 8M | 8.32M |
| Government Grant Revenue Revenue Growth | +41.16% | n/a | -100.00% | +59.94% | -3.87% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 |
|---|---|---|---|---|---|---|---|
| Emea Revenue | 373.57M | 367.41M | 147.49M | 132.76M | 130.53M | 134.36M | 30.18M |
| Emea Revenue Growth | +1.68% | +149.11% | +11.09% | +1.71% | -2.85% | +345.15% | n/a |
| Other Foreign Countries Revenue | 203.84M | 195.31M | 227.01M | 227.61M | 212.34M | 211M | 979.94M |
| Other Foreign Countries Revenue Growth | +4.37% | -13.96% | -0.26% | +7.20% | +0.64% | -78.47% | n/a |
| United States Revenue | 1.44B | 1.46B | 941.81M | 910.63M | 923.34M | 1.05B | n/a |
| United States Revenue Growth | -1.37% | +55.03% | +3.42% | -1.38% | -12.45% | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 162.71M | 159.55M | 157.66M | 154.62M | 148.61M | 150.9M | 152.57M | 142.93M | 153.45M | 158.75M | 153.21M | 81.46M | 74.81M | 73.92M | 72.39M | 73.55M | 70.85M | 67.24M | 72.31M | 70.65M | 65.88M | 67.82M | 72.63M | 79.54M | 78.07M | 83.54M | 87M | 77.14M | 76.82M | 85.11M | 64.89M | 22.6M | 22.36M | 22.49M | 21.98M | 22.52M | 20.21M | 20.32M | 20.17M |
| Selling, General, and Administrative Revenue Growth | +1.98% | +1.20% | +1.97% | +4.04% | -1.51% | -1.10% | +6.74% | -6.85% | -3.34% | +3.61% | +88.09% | +8.88% | +1.21% | +2.11% | -1.58% | +3.81% | +5.37% | -7.00% | +2.34% | +7.25% | -2.87% | -6.62% | -8.69% | +1.89% | -6.55% | -3.98% | +12.78% | +0.42% | -9.74% | +31.16% | +187.13% | +1.06% | -0.57% | +2.35% | -2.42% | +11.45% | -0.55% | +0.71% | n/a |
| Research and Development Revenue | 21.03M | 23.39M | 21.84M | 22.41M | 20.87M | 22.3M | 19.76M | 23.45M | 23.11M | 22.56M | 23.87M | 13.17M | 12.24M | 11.38M | 10.71M | 11.8M | 10.13M | 10.28M | 10.75M | 12.59M | 12M | 11.2M | 12.82M | 13.53M | 13.18M | 13.57M | 12.59M | 13.88M | 12.77M | 12.97M | 11.64M | 2.65M | 3.65M | 3.34M | 3.31M | 4.06M | 4.23M | 3.12M | 4.31M |
| Research and Development Revenue Growth | -10.10% | +7.09% | -2.54% | +7.38% | -6.42% | +12.86% | -15.72% | +1.48% | +2.41% | -5.48% | +81.31% | +7.58% | +7.49% | +6.31% | -9.22% | +16.50% | -1.49% | -4.35% | -14.63% | +4.87% | +7.17% | -12.66% | -5.19% | +2.61% | -2.90% | +7.86% | -9.30% | +8.67% | -1.53% | +11.39% | +338.62% | -27.29% | +9.35% | +0.75% | -18.34% | -4.02% | +35.39% | -27.53% | n/a |